Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmin (Human) in Acute Ischemic Stroke
NCT01014975Phase 2Completed
- Sponsor
- Grifols
- Start
- Nov 2009
- Primary completion
- Nov 2013
- Modality
- Therapeutic Enzymes
- Countries
- 6
01
Overview
Phase 2, open-label trial of plasmin in ischemic stroke (3 arms), sponsored by Grifols. Primary endpoint: Incidence of Symptomatic Intracranial Hemorrhage at 90 days. Started Nov 2009; status: completed.
02
Drugs
plasmin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01014975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014975.